[forum-prof] Monsanto, Roche e citações bibliográficas ...

[LuizEduardo2]

Pois é...
Não me consta que os convênios com o MST 
influenciem as citações dos professô-publicadô.
L.E.

=========================================


http://www.medscape.com/viewarticle/580356


Industry-Sponsored Trials More Widely Cited Than Not-for-Profit Studies

from 
<http://www.theheart.org>Heart<http://www.theheart.org>wire 
­ a professional news service of WebMD



Michael O'Riordan

advertisement


Information from Industry

<http://as.webmd.com/event.ng/Type=click&FlightID=28454&AdID=47532&TargetID=7839&Values=205&Redirect=http:/www.medscape.com/infosite/pointofcaretesting?src=0_0_ad_rct>The 
Institute for Advances in Point-of-Care Testing
Keep up with emerging trends in glycemic control, 
anticoagulation management, and other areas of 
point-of-care testing, to help reduce costs, 
enhance the efficacy of healthcare management, and improve patient outcomes.



September 10, 2008 (Boston, MA) ­ Cardiovascular 
clinical trials sponsored by industry are more 
likely to be cited in future medical publications 
than studies performed by not-for-profit 
organizations, a new study has shown [1]. Efforts 
should be made to ensure that important trials 
conducted by government agencies, such as the 
National Institutes of Health (NIH), are more 
widely disseminated to the cardiovascular community, say investigators.

"As a researcher, my core belief is that 
high-quality research gets done by the NIH and by 
industry, and the quality of our patients' lives 
will improve if this information is transmitted 
to the medical community," senior investigator Dr 
Paul Ridker (Brigham and Women's Hospital, 
Boston, MA) told heartwire. "What we observed is 
that the translation to practice is more rapid 
and thorough for industry-funded studies. We hope 
there can be a mechanism to do a better job 
promoting the findings of federally funded studies as well."

The results of the study, with first author Dr 
David Conen (Brigham and Women's Hospital), are 
published online September 8, 2008 in Circulation.

Responding to High-Quality Work

In 2006, Ridker and colleagues published a study 
showing that cardiovascular clinical trials 
funded by for-profit sponsors were significantly 
more likely to have positive results than trials 
reported by not-for-profit funding sources. He 
told heartwire that while the initial publication 
has an impact on clinical practice, how often the 
paper is cited in subsequent medical publications 
also has an effect on physician behavior.

The purpose of this study, explained Ridker, was 
to examine how the cardiovascular community 
responded to high-quality research funded by 
different sources. To do so, the Harvard 
researchers analyzed 303 consecutive superiority 
trials of cardiovascular medicine published 
between January 1, 2000 and July 30, 2005 in the 
Journal of the American Medical Association, the 
Lancet, and the New England Journal of Medicine. 
They then determined the number of citations per 
publication per year, a metric used to ascertain 
how the medical community was responding to the findings.

Investigators observed that industry-funded 
studies had more citations per publication per 
year than NIH- or other federally funded studies. 
This was true in all settings except for one: 
industry-funded studies were not cited as 
frequently when the studies failed to show a benefit.




Citations Per Publication Per Year According to Funding Source
(...)










============================ 
-------------- next part --------------
An HTML attachment was scrubbed...
URL: <http://listas.if.ufrj.br/pipermail/forum-prof/attachments/20080917/06644258/attachment.html>
-------------- next part --------------
A non-text attachment was scrubbed...
Name: clip_image002.gif
Type: image/gif
Size: 296 bytes
Desc: not available
URL: <http://listas.if.ufrj.br/pipermail/forum-prof/attachments/20080917/06644258/attachment.gif>